ORAGENICS, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ORAGENICS, INC. stock issued during period, value, issued for services for the quarter ending 2023-09-30 was $849.81K.
- ORAGENICS, INC. stock issued during period, value, issued for services for the quarter ending 2019-06-30 was $6.00K.
- ORAGENICS, INC. stock issued during period, value, issued for services for the quarter ending 2019-03-31 was $6.00K.
- ORAGENICS, INC. stock issued during period, value, issued for services for the quarter ending 2018-09-30 was $6.00K.
- ORAGENICS, INC. stock issued during period, value, issued for services for fiscal 2023 was $849.93K.
- ORAGENICS, INC. stock issued during period, value, issued for services for fiscal 2019 was $12.00K, a 0.00% change from fiscal 2018.
- ORAGENICS, INC. stock issued during period, value, issued for services for fiscal 2018 was $12.00K.
- ORAGENICS, INC. stock issued during period, value, issued for services for fiscal 2013 was $2.63M, a 1557.93% increase from fiscal 2012.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2023-12-31 | $849.93K 10-K · filed 2025-03-14 | |
| 2023-09-30 | $849.81K 10-Q · filed 2024-11-13 | |
| 2019-12-31 | $12.00K 10-K · filed 2021-03-01 | |
| 2019-06-30 | $6.00K 10-Q · filed 2020-11-10 | |
| 2019-03-31 | $6.00K 10-Q · filed 2020-11-10 | |
| 2018-12-31 | $12.00K 10-K · filed 2020-03-04 | |
| 2018-09-30 | $6.00K 10-Q · filed 2019-11-14 | |
| 2013-12-31 | $2.63M 10-K · filed 2015-02-27 | |
| 2012-12-31 | $158.43K 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |